U.S. House · 117th Congress · H.R. 1384

Mainstreaming Addiction Treatment Act of 2021

To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V (such as buprenorphine) for maintenance or detoxification treatment, and for other purposes.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Paul TonkoD-NY-20
Introduced
February 25, 2021, in the House
Issue areas
Policy area
Crime and Law Enforcement (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (250)

203 Democrats, 47 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these

Signed on later